RelenzaActive Ingredient(s): Zanamivir
FDA Approved: * July 26, 1999
Pharm Company: * GLAXOSMITHKLINE
Zanamivir is a medication used to treat and prevent influenza caused by influenza A and B viruses. It is a neuraminidase inhibitor and was developed by the Australian biotech firm Biota Holdings. It was licensed to Glaxo in 1990 and approved in the US in 1999, only for use as a treatment for influenza. In 2006, it was approved for prevention of influenza A and B. Zanamivir was the first neuraminidase inhibitor commercially developed. It is currently marketed by GlaxoSmithK... [wikipedia]* May have multiple approval dates, manufacturers, or labelers.
Relenza 5 mg/1 Respiratory (Inhalation) PowderNDC: 0173-0681
Relenza 5 mg/1 Respiratory (Inhalation) PowderNDC: 54868-4377
Physicians Total Care, Inc.
Relenza 5 mg/1 Respiratory (Inhalation) PowderNDC: 68258-3030
Dispensing Solutions Inc.
Relenza for influenza
Does anyone have experience using Relenza to treat or prevent the flu? ## Hello, Ldkat! How are you? I've never take...1 REPLY